Planta Med 2001; 67(2): 136-141
DOI: 10.1055/s-2001-11504
Original Paper

© Georg Thieme Verlag Stuttgart · New York

Anticonvulsant Properties and Bio-Guided Isolation of Palmitone from Leaves of Annona diversifolia 1

María Eva González-Trujano2, 3, 4 , Andrés Navarrete2,*, Benito Reyes5 , Ernestina Cedillo-Portugal6 , Enrique Hong4
  • 1 Taken in part from the Ph. D. research work of M.E. González-Trujano
  • 2 Facultad de Química, Departamento de Farmacia. Universidad Nacional Autónoma de México, México D. F., México
  • 3 Instituto Mexicano de Psiquiatría, México, D. F., México
  • 4 Sección de Terapéutica Experimental. Departamento de Farmacología y Toxicología. CINVESTAV IPN, México, D.F., México
  • 5 Laboratorio de Productos Naturales. Area de Química. Universidad Autónoma Chapingo, México
  • 6 Area de Biología. Universidad Autónoma Chapingo, México
Further Information

Publication History

February 11, 2000

July 2, 2000

Publication Date:
31 December 2001 (online)

Preview

Abstract

The activity-guided fractionation of the ethanol extract of leaves of Annona diversifolia Saff., led to the isolation of palmitone (16-hentriacontanone) as the only anticonvulsant active compound. This aliphatic ketone was highly effective to diminish pentylenetetrazole (PTZ)-induced clonic-tonic seizures and toxicity. Also, it produced a prolongation of the latency for onset of seizures and a reduction of the death rate produced by 4-aminopyridine (4-AP) and bicuculline (BIC). However, it was inactive to inhibit the kainic acid (KA)- and strychnine (STC)-induced seizures. Palmitone did not produce motor incoordination and loss of righting reflex which are used as signs of neurological impairment. Palmitone (ED50 = 1.85 mg/kg) proved to be a more potent antiepileptic drug against the PTZ-induced seizures than etosuximide (ED50 = 59.6 mg/kg), sodium valproate (ED50 = 63 mg/kg), and carbamazepine (ED50 > 300 mg/kg) and it was only four-fold less potent than diazepam (ED50 = 0.48 mg/kg). The pharmacological profile of palmitone suggests that this compound could be acting on the GABAergic inhibitory system.

References

Dr. Andrés Navarrete

Facultad de Química Conjunto E,

Departamento de Farmacia

Universidad Nacional Autónoma de México

Coyoacán 04510

México D.F.

México

Email: anavarrt@servidor.unam.mx.

Fax: (5) 6 22 53 29

Phone: (5) 6 22 52 91